TTRXNGMHealthcare·Biotechnology#359 in industry

Turn Therapeutics Inc.

Reports in 16d· 2026-05-13

-24.9% · 90d

$3.70

+0.15 (+4.37%)

After-Hours $3.48(-0.22)

News

(1)

March 2026

Mar 31, 20263 weeks ago8-KHealthcare

Turn Therapeutics Inc. — 8-K Filing

TTRXTurn Therapeutics Inc.

# 🧾 What This Document Is This is an **8-K filing**, which is a mandatory report to the SEC that companies use to announce major news to investors. Attached is their full press release. Think of it as the company's official news bulletin, sharing their financial scorecard for 2025 and exciting upda

Read summaryView on SEC EDGAR

Key Data

Market Cap$110.2M

Open$3.50

Prev Close$3.54

Day Range$3.50 – $3.70

52W Range$2.57 – $26.50

Volume12,364

P/E (TTM)—

EPS$-0.12

Dividend Yield—

Beta—

Price Target$8.00(+116.2%)

Next Earnings2026-05-13(16d)

Analyst Ratings

Strong Buy1 analysts

Buy 1Hold 0Sell 0

About

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Healthcare · Biotechnology

2 employees

www.turntherapeutics.com